A pharmaceutical composition comprising an immunoglobulin Fc region as a carrier

Details for Australian Patent Application No. 2004282985 (hide)

International Classifications

Event Publications

30 June 2005 Application Open to Public Inspection

Published as AU-B-2004282985

30 June 2005 PCT application entered the National Phase

PCT publication WO2005/047337 Priority application(s): WO2005/047337

14 August 2008 Application Accepted

Published as AU-B-2004282985

2 October 2008 Corrigenda

Applications Accepted - Name Index Under the name Hanmi Pharmaceutical Co., Ltd., Application No. 2004282985, under INID(43), correct the date to read 26.05.2005.

11 December 2008 Standard Patent Sealed

23 December 2010 Alteration of Name

The name of the patentee has been altered to Hanmi Holdings Co., Ltd.

20 September 2012 Assignment Registered

Hanmi Holdings Co., Ltd. The patent has been assigned to Hanmi Science Co., Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.